Seroprevalence studies

SARS-CoV-2 seroepidemiologic studies need to improve reporting

A CITF-funded study, published in preprint and not yet peer-reviewed, found that the reporting of SARS-CoV-2 seroepidemiologic studies needs improvement, particularly in providing adequately detailed information about laboratory methods. Researchers showed that there was a median adherence to reporting items of 48% per study, as evaluated via the Reporting of Seroepidemiologic studies—SARS-CoV-2 (ROSES-S) guideline.

2023-07-19T11:15:06-04:00July 12, 2023|Seroprevalence studies|

Infection-acquired seroprevalence increases moderately in early October: Canadian Blood Services

According to Canadian Blood Services, the infection-acquired antibody rate increased moderately from 65.4% in the last week of September to 66.3% by mid-October, consistent with the continued circulation of Omicron subvariants. Seroprevalence due to infection surpassed 80% among young donors (17-24 years of age) and 70% among the most materially deprived.

2022-11-28T16:41:25-05:00November 28, 2022|Seroprevalence studies|
Go to Top